20.5 C
New York
Sunday, June 7, 2026

Tag: tracers

newssourceFORcompanyinformationcontent1marketreleases

RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA¹ and Revises Upwards 2025 Financial Guidance Ranges

LOS ANGELES, Aug. 10, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 405 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2025.

Bracco Imaging Receives Regulatory Approval in China for SonoVue® in the Assessment of Fallopian Tube Patency

New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China MILAN, Aug. 5, 2025 /PRNewswire/ -- Bracco Imaging, a global...

Angelini Ventures Co-leads CHF 79 Million (€84 Million) Series B Financing of NUCLIDIUM to Advance Clinical Development of its Copper-based Radiopharmaceutical Platform

 - Regina Hodits, Managing Director to join NUCLIDIUM’s Board of Directors

Bracco Imaging Earns EcoVadis Platinum Medal for Global Sustainability Leadership

Award places company in top 1% of organizations rated globally for environmental, social, and ethical practices MILAN, July 10, 2025 /PRNewswire/ -- Bracco Imaging, a...

Bracco Imaging Earns EcoVadis Platinum Medal for Global Sustainability Leadership

Award places company in top 1% of organizations rated globally for environmental, social, and ethical practices MILAN, July 10, 2025 /PRNewswire/ -- Bracco Imaging, a...

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

−  Results show delivery of high radiation doses to tumours compared with normal organs.−  Observed normal organ absorbed dosimetry results may allow administration of...

Blue Earth Therapeutics: SNMMI Presentation of Results from Lutetium (177Lu) rhPSMA-10.1 Injection Phase 1 Clinical Trial

−  Results show delivery of high radiation doses to tumours compared with normal organs.−  Observed normal organ absorbed dosimetry results may allow administration of...

Weekly Recap: 11 Tech Press Releases You Need to See

A roundup of the most newsworthy tech announcements from PR Newswire this week, including Skypoints's AI agents, Bybit's new platform & Synopsys advancements in...

Radiopharmaceuticals Market Set to Grow with 16.4% CAGR from 2024 to 2029

"Therapeutic Radiopharmaceuticals to Lead Market Growth with Over 29.0% CAGR; New PET Tracers Expected to Drive Expansion by 2029" 
"Therapeutic Radiopharmaceuticals to Lead Market Growth with Over 29.0% CAGR; New PET Tracers Expected to Drive Expansion by 2029"

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTracers

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers